Carvalho E M, Bacellar O, Barral A, Badaro R, Johnson W D
Department of Medicine, University of Bahia, Salvador, Brazil.
J Clin Invest. 1989 Mar;83(3):860-4. doi: 10.1172/JCI113969.
Visceral leishmaniasis is associated with an antigen-specific immunosuppression during the acute disease. Patients become responsive to Leishmania antigen in both in vivo and in vitro assays after successful antimony therapy. The cell type involved in the suppression of lymphocyte reactivity to Leishmania antigen was studied by selective depletion of mononuclear cell (MNC) populations and in co-cultivation experiments. Adherent cells were depleted on plastic and by passage on nylon wool columns. High-avidity Fc+ cells were depleted by adherence to BSA-anti-BSA complexes and OKT4+ and OKT8+ cells were depleted by treatment with monoclonal antibody (anti-OKT4+ and OKT8+) and complement. Depletion of MNC preparations of adherent cells, high-avidity Fc+ cells, OKT4+ cells and OKT8+ cells failed to restore the lymphocyte reactivity to Leishmania antigen. Antimony therapy was associated with restoration of the proliferative responses of unseparated MNC (before treatment 460 +/- 76 cpm and after treatment 4,293 +/- 1,442 cpm). Co-culture of frozen cells obtained before chemotherapy with autologous MNC obtained after treatment reduced the response of posttreatment cells to Leishmania antigen by 80%. We conclude that the antigenic specific suppression of lymphocyte proliferation in visceral leishmaniasis is cell mediated.
内脏利什曼病在急性期与抗原特异性免疫抑制有关。成功进行锑剂治疗后,患者在体内和体外试验中对利什曼原虫抗原均有反应。通过选择性去除单核细胞(MNC)群体以及共培养实验,研究了参与抑制淋巴细胞对利什曼原虫抗原反应性的细胞类型。通过在塑料上贴壁以及在尼龙毛柱上传代来去除贴壁细胞。通过与牛血清白蛋白 - 抗牛血清白蛋白复合物结合来去除高亲和力Fc⁺细胞,并用单克隆抗体(抗OKT4⁺和抗OKT8⁺)及补体处理来去除OKT4⁺和OKT8⁺细胞。去除贴壁细胞、高亲和力Fc⁺细胞、OKT4⁺细胞和OKT8⁺细胞的MNC制剂未能恢复淋巴细胞对利什曼原虫抗原的反应性。锑剂治疗与未分离的MNC增殖反应的恢复有关(治疗前为460±76 cpm,治疗后为4293±1442 cpm)。化疗前获得的冻存细胞与治疗后获得的自体MNC共培养,使治疗后细胞对利什曼原虫抗原的反应降低了80%。我们得出结论,内脏利什曼病中淋巴细胞增殖的抗原特异性抑制是细胞介导的。